Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1508 ARTÍCULOS , VIENDO DEL 1441 AL 1455

The Evolution of Genetics: Alzheimer's and Parkinson's Diseases

Singleton A, Hardy J.

Neuron. 2016 Jun 15;90(6):1154-1163. doi: 10.1016/j.neuron.2016.05.040.

A review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer's disease and Parkinson's disease

McGhee DJ, Ritchie CW, Zajicek JP, Counsell CE.

BMC Neurol. 2016 Jun 16;16:92. doi: 10.1186/s12883-016-0606-3.

Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease

Malek N, Lawton MA, Swallow DM, Grosset KA, Marrinan SL, Bajaj N, Barker RA, Burn DJ, Hardy J, Morris HR, Williams NM, Wood N, Ben-Shlomo Y, Grosset DG; PRoBaND Clinical Consortium.

Mov Disord. 2016 Oct;31(10):1518-1526. doi: 10.1002/mds.26698.

Nucleic acid oxidative damage in Alzheimer's disease-explained by the hepcidin-ferroportin neuronal iron overload hypothesis?

Hofer T, Perry G.

J Trace Elem Med Biol. 2016 Dec;38:1-9. doi: 10.1016/j.jtemb.2016.06.005. Epub 2016 Jun 7.

[Endogenous Cannabinoid System of the Brain as the Target for Influences at Neurodegenerate Diseases]

Kitchigina VF.

Zh Vyssh Nerv Deiat Im I P Pavlova. 2016 Jul;66(4):387-413.

Neurocognitive Deficits Distinguishing Mild Dementia with Lewy Bodies from Mild Alzheimer's Disease are Associated with Parkinsonism

Brønnick K, Breitve MH, Rongve A, Aarsland D.

J Alzheimers Dis. 2016 Jun 30;53(4):1277-85. doi: 10.3233/JAD-160294.

Metallo-pathways to Alzheimer's disease: lessons from genetic disorders of copper trafficking

Greenough MA, Ramírez Munoz A, Bush AI, Opazo CM.

Metallomics. 2016 Sep 1;8(9):831-9. doi: 10.1039/c6mt00095a. Epub 2016 Jul 11.

(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study

Tiraboschi P, Corso A, Guerra UP, Nobili F, Piccardo A, Calcagni ML, Volterrani D, Cecchin D, Tettamanti M, Antelmi L, Vidale S, Sacco L, Merello M, Stefanini S, Micheli A, Vai P, Capitanio S, Gabanelli SV, Riva R, Pinto P, Biffi AM, Muscio C; SCILLA Working Group.

Ann Neurol. 2016 Sep;80(3):368-78. doi: 10.1002/ana.24717. Epub 2016 Aug 2.

Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study

Leuzy A, Chiotis K, Hasselbalch SG, Rinne JO, de Mendonça A, Otto M, Lleó A, Castelo-Branco M, Santana I, Johansson J, Anderl-Straub S, von Arnim CA, Beer A, Blesa R, Fortea J, Herukka SK, Portelius E, Pannee J, Zetterberg H, Blennow K, Nordberg A.

Brain. 2016 Sep;139(Pt 9):2540-53. doi: 10.1093/brain/aww160. Epub 2016 Jul 7.

Cerebrospinal Fluid Biomarkers for Target Engagement and Efficacy in Clinical Trials for Alzheimer's and Parkinson's Diseases

Parnetti L, Eusebi P, Lleó A.

Front Neurol Neurosci. 2016;39:117-23. doi: 10.1159/000445452. Epub 2016 Jul 26.

Metals in Alzheimer's and Parkinson's Disease: Relevance to Dementia with Lewy Bodies

McAllum EJ, Finkelstein DI.

J Mol Neurosci. 2016 Nov;60(3):279-288. doi: 10.1007/s12031-016-0809-5. Epub 2016 Aug 8.

Parkinson Disease and Dementia

Garcia-Ptacek S, Kramberger MG.

J Geriatr Psychiatry Neurol. 2016 Sep;29(5):261-70. doi: 10.1177/0891988716654985.

The Significance of the Default Mode Network (DMN) in Neurological and Neuropsychiatric Disorders: A Review

Mohan A, Roberto AJ, Mohan A, Lorenzo A, Jones K, Carney MJ, Liogier-Weyback L, Hwang S, Lapidus KA.

Yale J Biol Med. 2016 Mar 24;89(1):49-57. eCollection 2016 Mar.

Evolution of clinical features in possible DLB depending on FP-CIT SPECT result

Walker Z, Moreno E, Thomas A, Inglis F, Tabet N, Stevens T, Whitfield T, Aarsland D, Rainer M, Padovani A; DaTSCAN DLB Phase 4 Study Group.

Neurology. 2016 Sep 6;87(10):1045-51. doi: 10.1212/WNL.0000000000003076. Epub 2016 Aug 10.

Therapeutic Strategies for Alzheimer's and Parkinson's Diseases by Means of Drug Delivery Systems

Cunha S, Amaral MH, Lobo JM, Silva AC.

Curr Med Chem. 2016;23(31):3618-3631. doi: 10.2174/0929867323666160824162401.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias